Our Take on the FDA’s Recent Statement Regarding Oral Flea and Tick Prevention
On September 20, 2018, the Food and Drug Administration released a statement regarding the isoxazoline class of drugs – which are the oral flea and tick preventatives such as Simparica, Nexgard, Bravecto, and Credelio.
It is important to note that this statement did not alter any past recommendations related to these medications’ safety or efficacy. It was meant to inform the general public about potential side
effects associated with them. This class of preventatives remains safe, and most patients will
never experience side effects, but as with any medication, it is something that has to be discussed with your veterinarian.
You can read the full statement by clicking on this link https://www.fda.gov/AnimalVeterinary/NewsEvents/CVMUpdates/ucm620934.htm
If you have any questions, don’t hesitate in giving us a call at 816.333.4330.